Equity Analysis

Quarterly Results

    Divis Laboratories Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs
    BSE Code
    ISIN Demat
    Book Value()
    532488
    INE361B01024
    507.93558
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    DIVISLAB
    94.22
    156497.71
    EPS(TTM)
    Face Value()
    Div & Yield %:
    62.57
    2
    0.51
     
Quarters
(RupeeIcon Cr)
ParticularsJun 2024Mar 2024Dec 2023
Gross Sales2063.002259.001808.00
Other Operating Income0.000.000.00
Other Income 79.0079.0094.00
Total Income2142.002338.001902.00
Total Expenditure 1442.001542.001317.00
PBIDT700.00796.00585.00
Interest 0.002.000.00
PBDT700.00794.00585.00
Depreciation97.0094.0095.00
Tax178.00159.00121.00
Fringe Benefit Tax0.000.000.00
Deferred Tax-5.0010.0011.00
Reported Profit After Tax430.00531.00358.00
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item430.00531.00358.00
EPS (Unit Curr.)16.1819.9913.50
EPS (Adj) (Unit Curr.)16.1819.9913.50
Calculated EPS (Unit Curr.)16.2320.0413.51
Calculated EPS (Adj) (Unit Curr.)16.2320.0413.51
Calculated EPS (Ann.) (Unit Curr.)64.9180.1554.04
Calculated EPS (Adj) (Ann.) (Unit Curr.)64.9180.1554.04
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity53.0053.0053.00
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)33.9335.2432.36
PBDTM(%)33.9335.1532.36
PATM(%)20.8423.5119.80
Dividend Per Share(Rs)0.000.000.00
Diluted EPS16.1819.9913.50